Liquid Dosage
Therapeutical Proteins
Protein-based therapeutics are increasingly being developed as new chemical entities in the pharmaceutical and life science industries. Unlike small molecules, which are typically synthesized using chemical processes, most proteins need to be processed in living systems, mostly by recombinant DNA technology. The proteins can then be produced in their functional form (quaternary structure), rather than by microbial biosynthesis (bacteria/yeast), substantially reducing the downstream stages of the process.
The GEA Advantage
As the demand for large-volume products increases, so does the requirement for higher capacity reactors (up to 20,000 L) to realize economies of scale. GEA has responded to the changing needs of biopharmaceutical manufacturers and developed improved technology solutions to optimize both upstream and, with increasing titers, downstream processing, in terms of time and cost efficiency.
Based on its history of innovation and process development, GEA has a thorough working knowledge of therapeutic protein production and has used this competence to design better media and feeding strategies, optimize the fermentation stage and enhance physicochemical conditions during the manufacturing process.
A leading international supplier of integrated process systems, our extensive portfolio of products, technologies and services includes standard and customized fermenters, separators and entire production lines, as well as plant for the production, storage and distribution of clean utilities. Systems for the preparation of media, fluid management, cell cultivation and purification are also part of our global scope of supply.
As a competent manufacturer of complete plant for the life science industries, GEA is a full-service provider of solutions that meet your exact requirements and specifications. From planning, development and installation to qualification and maintenance, our experienced engineers will collaborate with your project team to supply innovative and efficient process solutions for your applications.
Produkty i technologie
Wyświetlane elementy: 4 z 29
Analityczne liniowe urządzenia do kontroli i pomiaru
Połączenie monitorowania procesu z analizatorami w linii wraz z solidnymi zasadami projektowania procesu i zaawansowanymi technikami modelowania procesu umożliwi aktywne sterowanie procesem w celu kompensacji zmian sygnału wejściowego.
Homogenizatory laboratoryjne
Homogenizatory laboratoryjne od GEA, małe i kompaktowe, pozwalają testować wpływ homogenizacji na produkt oraz ustalać najlepsze parametry procesowe.
Homogenizatory przemysłowe
Homogenizatory GEA to urządzenia złożone z dwóch zasadniczych elementów: bloku sprężającego, który umożliwia pompie tłokowej wytwarzanie wysokiego ciśnienia, oraz zaworu homogenizującego zdolnego do mikronizacji rozproszonych cząstek do mikrometrów lub nanometrów, w zależności od właściwości produktu i zamierzonych rezultatów.
Homogenizatory z montażem na stałe
Od pewnego czasu GEA ustala standardy w zakresie homogenizatorów pozwalających pracować z bardzo wysokimi ciśnieniami (VHP) do zastosowań w przemyśle farmaceutycznym i biotechnologicznym. Nasz zakres dostaw sięga od maszyn laboratoryjnych, przez projektowanie pilotowych i produkcyjnych systemów modułowych do lizy komórek oraz redukcji rozmiaru cz...
Downloads
GEA Insights
In for the better: Community engagement at GEA
To support community engagement, GEA offers employees one day of paid time off per year.
How a digital rotary parlor supports sustainable dairy farming
How do you lead a dairy farm into the next generation while ensuring a sustainable future and animal welfare while managing increasing complexity? This is a question almost every dairy farmer around the world must consider. The...
A strategy for the better: CEO interview on GEA's Mission 30
After reaching its Mission 26 targets two years early, GEA launches Mission 2030 strategy with focus on growth, value and making a positive impact.
